Search Results "#drugs"

Blogs

arrow_forward View More Results
Herpes Labialis Drugs Market: Why Hasn't a Cure Replaced Acyclovir After Four Decades?
Posted by Surbhi on July 17 2026 at 04:12 PM   public
The herpes labialis drugs market — prescription and over-the-counter antiviral therapies used to treat cold sores caused by herpes simplex virus type 1 (HSV-1), spanning topical creams, oral anti...
Erectile Dysfunction (ED) Drugs Market to Surpass US$ 9.2 Billion by 2035, Driven by Rising Disease Prevalence, Expanding Telehealth Adoption, and Continuous Pharmaceutical Innovation
Posted by Mayur on July 15 2026 at 01:48 PM   public
The global Erectile Dysfunction (ED) Drugs Market represents one of the largest segments within the men's sexual health therapeutics industry. Erectile dysfunction affects an estimated 150–200 mi...
Multiple Sclerosis Drugs Market to Reach USD 39.7 Billion by 2036, Driven by Rising MS Prevalence and Growing Adoption of High-Efficacy Disease-Modifying Therapies
Posted by Mayur on June 25 2026 at 05:09 PM   public
Multiple Sclerosis Drugs Market Overview Multiple sclerosis (MS) drugs are therapeutic agents used to manage multiple sclerosis, a chronic autoimmune disease that affects the central nervous sys...
Anti-malarial Drugs Market Future Scope, Demands and Projected Industry Growths to 2033
Posted by Sunil Basnet on June 16 2026 at 11:23 AM   public
The comprehensive use of integrated methodologies yields a wonderful Anti-malarial Drugs Market research report that plays an imperative part to shape the decision-making procedures of the busine...
From Non-Specific Immunosuppression to Dual-Cytokine Pathway Inhibition: How Molecular Targeting is Scaling Autoimmune Therapeutics
Posted by Jack william on June 02 2026 at 06:22 PM   public
The global immunology sector, biopharmaceutical manufacturing pipeline, clinical rheumatology space, and specialized healthcare delivery networks are undergoing a massive shift centered on early ...
arrow_forward